Alexion pulls Soliris vials on particle-contamination worries

Alexion ($ALXN) had to recall more vials of its rare-disease treatment Soliris because particles were found in some of them. The move comes as Roche ($RHHBY) is reportedly eyeing a bid for the U.S.-based drugmaker. Report